Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Abingworth, a leading international life sciences investment group, announces the appointment of Joy Ghosh, PhD as Managing Director. Joy will be...
Abingworth, a leading international life sciences investor, announces its portfolio company Adaptate Biotherapeutics ("Adaptate") is to be acquired...
Abingworth, a leading international life sciences investor, today announced the further strengthening of its investment team with the appointment of...
Abingworth, a leading international life sciences investor, announces its portfolio company GammaDelta Therapeutics is to be acquired by Takeda...
Abingworth, a leading international life sciences investment group, announces three new appointments to its investment team in the UK and US. Jay Cui ...
Abingworth, a leading international life sciences investment group, today announced the final closing of its new Clinical Co-Development Fund at $582 ...
Abingworth, a leading international life sciences investment group, today announced the final closing of its latest transatlantic venture fund,...
Abingworth, the international investment group dedicated to life sciences, is pleased to announce the promotion of Bali Muralidhar MD PhD to Managing ...
Abingworth, the international investment group dedicated to life sciences, today announced the appointment of Neil Cooper as Chief Financial Officer, ...
Abingworth, the international investment group dedicated to life sciences, today announced the appointment of Bali Muralidhar as a Partner based in...
Abingworth, the international investment group dedicated to life sciences, today announced that Jackie Grant, PhD, MBA, will join Abingworth as a...
Abingworth, the international investment group dedicated to life sciences, today announced the final closing of its latest fund, Abingworth...
Abingworth, the international investment group dedicated to life sciences, today announced that it has seeded GammaDelta Therapeutics Ltd, a new...
Abingworth, the international investment group dedicated to life sciences, today announced the closing of the $105m Abingworth Clinical...
Abingworth, the international investment group dedicated to life sciences, today announced that Shelley Chu, MD, PhD has joined Abingworth as a...
Abingworth, the international investment group dedicated to life sciences and healthcare, today announced that Tim Haines and Kurt von Emster, have...
Abingworth, the international investment group dedicated to life sciences and healthcare, today announced the appointment of Kurt von Emster as a...
Abingworth, the international investment group dedicated to life sciences and healthcare, today announced the promotions of Ken Haas and Vin Miles to ...
Abingworth, the international investment group dedicated to life sciences and healthcare, today announced the final closing of its £225m ($375m)...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.